| |
| |
|
| Insider
Information: |
Fambrough Douglas |
| Relationship: |
Chief Executive Office... |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -14.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dicerna Pharmaceuticals Inc |
DRNA |
Chief Executive Office... |
2021-12-28 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2021-12-28 |
4 |
D |
$38.25 |
$8,852,236 |
D/D |
(231,431) |
0 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2021-12-15 |
4 |
D |
$38.05 |
$203,491 |
D/D |
(5,348) |
231,431 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2021-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,750 |
236,779 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2021-12-10 |
4 |
OE |
$2.97 |
$599,987 |
D/D |
179,865 |
223,029 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
President and CEO |
• • – |
2021-08-10 |
4 |
B |
$22.10 |
$110,480 |
D/D |
5,000 |
43,164 |
2.81 |
% |
|
| DRNA |
Dicerna Pharmaceuticals I... |
President and CEO |
• • – |
2021-01-08 |
4 |
D |
$23.29 |
$143,443 |
D/D |
(6,159) |
37,030 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
President and CEO |
• • – |
2021-01-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,950 |
43,189 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
President and CEO |
• • – |
2020-09-01 |
4 |
B |
$18.06 |
$180,597 |
D/D |
10,000 |
22,300 |
2.81 |
% |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2019-12-18 |
4 |
S |
$25.85 |
$2,069,586 |
D/D |
(80,000) |
12,300 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2019-12-18 |
4 |
OE |
$3.42 |
$273,600 |
D/D |
80,000 |
92,300 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2019-12-17 |
4 |
S |
$26.13 |
$1,544,345 |
D/D |
(59,021) |
12,300 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2016-11-15 |
4 |
B |
$3.63 |
$59,895 |
D/D |
16,500 |
55,579 |
2.81 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2016-11-14 |
4 |
B |
$3.78 |
$62,748 |
D/D |
16,600 |
39,079 |
2.81 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2014-12-17 |
4 |
OE |
$3.42 |
$8,550 |
D/D |
2,500 |
19,800 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2014-01-29 |
4 |
B |
$15.00 |
$75,000 |
D/D |
5,000 |
17,300 |
2.81 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Executive OfficerOfficer |
• • – |
2014-01-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,300 |
|
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2013-11-11 |
4 |
OE |
$3.42 |
$31,806 |
D/D |
9,300 |
12,300 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
